OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories Sep 13, 2016
OPKO to Present Long-acting Human Growth Hormone (hGH-CTP) Phase 2 Pediatric Growth Hormone Deficiency Data at the 55th Annual Meeting of the European Society for Paediatric Endocrinology Sep 6, 2016
FDA Approves New Drug Application for RAYALDEE® to Treat Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Stage 3-4 Chronic Kidney Disease Jun 21, 2016
